These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22134117)

  • 1. Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.
    Shah PP; Desai PR; Singh M
    J Control Release; 2012 Mar; 158(2):336-45. PubMed ID: 22134117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
    Shah PP; Desai PR; Channer D; Singh M
    J Control Release; 2012 Aug; 161(3):735-45. PubMed ID: 22617521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs.
    Shah PP; Desai PR; Patel AR; Singh MS
    Biomaterials; 2012 Feb; 33(5):1607-17. PubMed ID: 22118820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II.
    Babu RJ; Kikwai L; Jaiani LT; Kanikkannan N; Armstrong CA; Ansel JC; Singh M
    Pharm Res; 2004 Jan; 21(1):108-13. PubMed ID: 14984264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles.
    Desai PR; Shah PP; Hayden P; Singh M
    Pharm Res; 2013 Apr; 30(4):1037-1049. PubMed ID: 23187866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
    Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
    Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases.
    Onishi H; Takahashi M; Machida Y
    Biol Pharm Bull; 2005 Oct; 28(10):2011-5. PubMed ID: 16204968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of ketoprofen: the influence of drug-dioleylphosphatidylcholine interactions.
    Garcia MT; da Silva CH; de Oliveira DC; Braga EC; Thomazini JA; Bentley MV
    Pharm Res; 2006 Aug; 23(8):1776-85. PubMed ID: 16858649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of enhancers on the permeation of ketoprofen in vitro].
    Hu JH; Zhu Y
    Yao Xue Xue Bao; 1996; 31(1):48-53. PubMed ID: 8762460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
    Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
    J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
    Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
    J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
    Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
    Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
    Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
    J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
    Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
    J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.
    Xu P; Gullotti E; Tong L; Highley CB; Errabelli DR; Hasan T; Cheng JX; Kohane DS; Yeo Y
    Mol Pharm; 2009; 6(1):190-201. PubMed ID: 19035785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch.
    Liu C; Guan Y; Tian Q; Shi X; Fang L
    Int J Pharm; 2019 Dec; 572():118800. PubMed ID: 31678378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.